Clinical trial

PET/CT-directed Hyperfractionated Radiation Dose Escalation in Stage III Non-small Cell Lung Cancer

NCT03099577

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-01-02

PhaseNA

Study timeline

Study start (actual)2017-01-02Date precision: day

Registry last updated2019-05-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

radiochemotherapy 1RADIATION

radiochemotherapy 2RADIATION

radiochemotherapy 3RADIATION

radiochemotherapy 4RADIATION

radiochemotherapy 5RADIATION

radiochemotherapy 6RADIATION

radiochemotherapy 7RADIATION

Sponsors & collaborators

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicinelead sponsor

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03099577 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.